Receive funding for your R&D Projects!
Your partner for subsidy advice
Your partner for subsidy advice
The new method allows investigators to quickly create a large number of TALENs (transcription activator-like effector nucleases), enzymes that target specific…
A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs' Endothelial Corneal…
Eleven patients took part in the study over a period of two to five years. A lasting reduction in symptoms of more than 50% was seen in nearly half of the…
The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such “personalized” drugs can be developed, more…
Previous studies have shown that both nuclear reprogramming as well as 'imprinting' are vital for the survival and later development of the embryo. However,…
A single-center study found that percutaneous coronary intervention (PCI) procedures performed during the middle of the night do not adversely affect the…